14 insiders reported 74 Form 4 transactions for Arcus Biosciences, Inc. (RCUS) over the past 18 months (most recent 2026-07-13). Recent activity: Jaen Juan C. (President) Sell 48,502 shares, Jaen Juan C. (President) Sell 19,799 shares, Jaen Juan C. (President) Sell 268 shares, Jaen Juan C. (President) Sell 9,236 shares, Jaen Juan C. (President) Sell 14,067 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-13 | Jaen Juan C. | President | Sell | 48,502 | $1.5M |
| 2026-07-13 | Jaen Juan C. | President | Sell | 19,799 | $566,410 |
| 2026-07-13 | Jaen Juan C. | President | Sell | 268 | $7,878 |
| 2026-06-24 | Jaen Juan C. | President | Sell | 9,236 | $249,661 |
| 2026-06-24 | Jaen Juan C. | President | Sell | 14,067 | $389,480 |
| 2026-06-24 | Jaen Juan C. | President | Sell | 1,697 | $47,620 |
| 2026-06-24 | Jaen Juan C. | President | Sell | 6,431 | $190,740 |
| 2026-06-12 | Lambert Nicole | Director | Buy | 5,700 | $0 |
| 2026-06-12 | FALBERG KATHRYN E | Director | Buy | 5,700 | $0 |
| 2026-06-12 | KANEKO YASUNORI | Director | Buy | 5,700 | $0 |
| 2026-06-12 | Machado Patrick | Director | Buy | 5,700 | $0 |
| 2026-06-12 | Lacey David L. | Director | Buy | 5,700 | $0 |
| 2026-06-12 | PERLMAN ANDREW J | Director | Buy | 5,700 | $0 |
| 2026-06-12 | Ribas Antoni | Director | Buy | 5,700 | $0 |
| 2026-06-12 | Tang Carolyn C. | General Counsel | Buy | 34,090 | $87,748 |
| 2026-06-01 | Azoy Alexander | Chief Accounting Officer | Sell | 2,562 | $66,024 |
| 2026-05-12 | Goeltz II Robert C. | Chief Financial Officer | Sell | 7,763 | $198,966 |
| 2026-05-12 | Ribas Antoni | Director | Sell | 5,050 | $0 |
| 2026-01-26 | Jarrett Jennifer | Chief Operating Officer | Buy | 31,000 | $0 |
| 2026-01-26 | Jaen Juan C. | President | Buy | 31,000 | $0 |
| 2026-01-26 | Goeltz II Robert C. | Chief Financial Officer | Buy | 24,000 | $0 |
| 2026-01-26 | ROSEN TERRY J | Chief Executive Officer | Buy | 79,000 | $0 |
| 2026-01-26 | Tang Carolyn C. | General Counsel | Buy | 24,000 | $0 |
| 2026-01-26 | Markus Richard | Chief Medical Officer | Buy | 24,000 | $0 |
| 2026-01-26 | Azoy Alexander | Chief Accounting Officer | Buy | 21,050 | $0 |
Source: SEC Form 4 filings · as of 2026-07-13